Latest Interviews
Showing 1–3 of 3 transcripts.
Clear all filters- Milken Institute31 min
Milken-Motsepe Prize Award Ceremony: Global Green Energy Winners | Global Conference 2024
Michael Milken, Patrice Motsepe, Emily Church, Randy Kabuya, Derick Nwasor, Diana Orembe, Jordan Oxley, Zoë Slattery, Jonathan Wilson, Mike Milken, Joy Egbe
Co-founded by Mike Milken and Patrice Motsepe, the Milken-Mozespe Innovation Prize Program has funded 45 companies across 20 nations to solve critical electricity and agricultural challenges in Sub-Saharan Africa. The initiative recently awarded its inaugural Green Energy Grand Prize of $1 million to Aftrac for its sustainable solar tractor model, while runner-up Omnivat received $250,000 for its modular container-based power grid. Building on this momentum, the program has announced a new $2 million Fintech award cycle designed to continue bridging economic opportunities between the United States and the continent.
- Milken Institute42 min
A Fireside Chat with Serge Pun Building Myanmar
Serge Pun, Staci Warden, Mike Milken, Mahendra Lama, Minseok Lee, Dickey Yuhuiko, Brad Gordon
Expanding from a private interview to a public forum, the Milken Institute session featured Serge Poon and Mike Milken discussing Myanmar's shifting economic landscape following the removal of US sanctions. Poon detailed his forty-year journey from displacement to rebuilding a private banking empire through strict anti-corruption practices, while outlining a strategy prioritizing long-term infrastructure investment over short-term gains. The dialogue concluded with an optimistic five-year forecast for nation-building, emphasizing regional connectivity and the need for investors to support foundational "trunk" projects despite lingering political risks.
- Milken Institute1h 11m
Lunch Panel: A Cure for What Ails Us: Celebrating the Impact of Science (updated II)
Nancy Brown, Francis Collins, Thomas Frieden, Andrew von Eschenbach, Michael Milken, Mike Milken, Tom Frieden, Andy Van Eschenbach, Jack Andreyka
A comprehensive analysis of global bioscience reveals a dramatic increase in life expectancy and major breakthroughs in disease eradication, such as the near-elimination of polio and HIV management through programs like PEPFAR. Despite these successes, the sector faces a critical funding crisis where declining NIH grant success rates and inflation-adjusted budget cuts threaten the pipeline of young researchers and the translation of genetic discoveries into new treatments. Strategic initiatives like the Brain Initiative, precision medicine efforts, and the shift toward prevention are now essential to address rising chronic disease burdens and sustain the bioscience industry as a primary driver of US economic growth.